London's children's hospital, where gene-edited 'universal' CAR-T cells were first given to a child with leukaemia.
Founded in 1852, Great Ormond Street Hospital is the UK's largest children's hospital and, with the UCL Great Ormond Street Institute of Child Health, one of Europe's leading paediatric research centres. In 2015 Waseem Qasim's team treated an infant with refractory leukaemia using TALEN-edited allogeneic CAR-T cells, the first such use in humans, and in 2022 the team delivered the first base-edited CAR-T (CD7-directed) for T-cell leukaemia. The hospital runs one of the UK's largest paediatric oncology and haematology services, including bone marrow transplantation, neuro-oncology and neuroblastoma programmes, and hosts the Zayed Centre for Research into Rare Disease in Children. It is a principal treatment centre for London and a national referral site for rare childhood cancers.
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-10-01.
Matched to Great Ormond Street Hospital, including child institutions. 154 works · 1,385 citations · 75% open access · 8% clinical trials · 5% reviews.
London paediatric neuro-oncologist who led the trial showing that dabrafenib and trametinib work in children with BRAF V600-mutant high-grade glioma.
Paediatric neurologist and Chief Medical Officer of Great Ormond Street Hospital, responsible for clinical standards and patient safety.
Delivered the first gene-edited off-the-shelf CAR-T cells to infants with leukaemia and the first base-edited CAR-T therapy.
Chief Executive of Great Ormond Street Hospital, the UK's leading children's hospital, since June 2026.
Shares Waseem Qasim, Allogeneic (off-the-shelf) cell therapy, Manufacturing cost and time for living and radioactive medicines, CD19.
Shares Innovative Therapies for Children with Cancer (ITCC), Neuroblastoma (paediatric), Rare and paediatric cancers without markets, CAR-T cell therapy.
Shares Allogeneic (off-the-shelf) cell therapy, CD19, CAR-T cell therapy, Acute lymphoblastic leukaemia.
Shares Allogeneic (off-the-shelf) cell therapy, Manufacturing cost and time for living and radioactive medicines, CD19, CAR-T cell therapy.
Shares Allogeneic (off-the-shelf) cell therapy, Neuroblastoma (paediatric), Glioma & glioblastoma, Acute lymphoblastic leukaemia.
Shares Manufacturing cost and time for living and radioactive medicines, CD19, CAR-T cell therapy, Acute lymphoblastic leukaemia.
Shares Allogeneic (off-the-shelf) cell therapy, CAR-T cell therapy, Acute lymphoblastic leukaemia, Acute myeloid leukaemia.
Shares Allogeneic (off-the-shelf) cell therapy, CAR-T cell therapy, Acute lymphoblastic leukaemia, Acute myeloid leukaemia.